No black box warning on record for Asenapine

As of the latest FDA labeling reviewed, Asenapine (ASENAPINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Asenapine medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Cerebrovascular Adverse Reactions in Elderly Patients with Dementia-Related Psychosis: Increased incidence of cerebrovascular adverse reactions (e.g., stroke, transient ischemic attack). ( 5.2 ) • Neuroleptic Malignant Syndrome: Manage with immediate discontinuation and close monitoring. ( 5.3 ) • Tardive Dyskinesia: Discontinue if clinically appropriate. ( 5.4 ) • Met

No black box warning on record for Asenapine

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Cerebrovascular Adverse Reactions in Elderly Patients with Dementia-Related Psychosis: Increased incidence of cerebrovascular adverse reactions (e.g., stroke, transient ischemic attack). ( 5.2 ) • Neuroleptic Malignant Syndrome: Manage with immediate discontinuation and close monitoring. ( 5.3 ) • Tardive Dyskinesia: Discontinue if clinically appropriate. ( 5.4 ) • Met

Asenapine Black Box Warning

No black box warning on record for Asenapine

Other warnings & precautions

Asenapine Black Box Warning

No black box warning on record for Asenapine

Other warnings & precautions